Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neuroendocrine Tumors
×
Temozolomide
×
Clear all
Filters
3
NCT04919226
2025-09-10
COMPOSE
ITM Solucin GmbH
Phase 3
Active not recruiting
259 enrolled
NCT02698410
2020-10-01
ATLANT
Ipsen
Phase 2
Completed
40 enrolled
17 charts